Wanbury completes Brazilian Health Authority audit at Tanuku plant facility

03 Jan 2025 Evaluate

Wanbury has successfully completed the Brazilian Health Authority (ANVISA) audit at its Tanuku plant facility in Andhra Pradesh in the month of December 2024 without any observations. This will enable the company to maintain and further solidify its position in this important market.

The facility has been upgraded to meet all global regulatory requirements and should meet the highest level of compliance standards. With the completion of upgradation, the company has started full-fledged manufacturing operations and the plant will now be running at optimum capacity to meet customer demand.

Wanbury, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation.


Wanbury Share Price

238.05 -6.55 (-2.68%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×